Magnetic resonance imaging evaluation of single axillary lymph node metastasis in breast cancer: Emphasis on the location of lymph nodes.
Haejung KimBoo Kyung HanEun Young KoEun Sook KoJi Soo ChoiPublished in: Medicine (2022)
To evaluate the frequency and location of abnormal lymph nodes (LNs) in breast cancer patients with a single axillary lymph node (ALN) metastasis on breast magnetic resonance imaging (MRI). We retrospectively reviewed the MRI findings of 219 consecutive patients with breast cancer with single ALN metastasis who were surgically confirmed at our institution between January 2018 and December 2018. The morphological features and locations of the abnormal LN on MRI were analyzed. Pathology reports were reviewed to evaluate the size of the metastases and whether they were sentinel LNs (SLNs). Of the 219 patients with a single ALN metastasis, 56 (25.6%) showed abnormal MRI findings. Of these, 54 (96.4%) had either the lowest or second-lowest LN in the level I axilla. In 184 (91.5%) of 201 patients who underwent SLN biopsy, the metastatic LN were SLN. Macrometastases were found more frequently in cases with abnormal LNs than in those with normal-looking LNs (P = .004). The most frequent morphological feature of metastatic ALNs was a diffuse cortical thickening of 3 to 5 mm (37.5%). Although MRI findings of single ALN metastasis in breast cancer patients are none or minimal, abnormalities are observed in the lowest or second-lowest LN in the lower axilla when present, suggesting the location of the SLNs.
Keyphrases
- lymph node
- magnetic resonance imaging
- sentinel lymph node
- contrast enhanced
- diffusion weighted imaging
- neoadjuvant chemotherapy
- lymph node metastasis
- squamous cell carcinoma
- computed tomography
- small cell lung cancer
- magnetic resonance
- end stage renal disease
- ejection fraction
- emergency department
- newly diagnosed
- machine learning
- deep learning
- young adults
- breast cancer risk
- peritoneal dialysis
- patient reported